Questions addressed Questions addressed
• Is there an easy way for the Otolaryngologist to determine if the patient presenting with a complaint of "sinus headache" is a patient suffering from migraine headache? • Can response to triptans be useful in diagnosing migraine headache?
Study Design Study Design
• Objective:
• assess the response rate to triptans in patients with "sinus headache" in absence of clinical sinusitis
• Inclusion Criteria:
• chief complaint of "sinus headache"
• negative nasal sinus endoscopy • CT negative for sinus disease within 6 months
• Exclusion Criteria:
• contraindications to triptan use
• cardiovascular disease, mitral valve prolapse, tachycardia
• Headache due to another identifiable cause
EMORY HEALTHCARE EMORY HEALTHCARE
• Intervention:
• eletriptan 40mg at onset of headache • Repeat after 2 hours if headache persisted • Every single headache was treated
• Patients followed up within 1-3 months • 34 patients with headache as one of their symptoms underwent ESS and relief of contact points
• Reduction of intensity and frequency of headaches in 91 and 85%, respectively • 13.9 months follow-up
• Too many confounding factors • 13% of patients in our study had contact points and responded to triptans.
Endosnasal surgery for Contact Point Headaches: a 10-year longitudinal study Welge-Leussen A, et al. Laryngoscope 2003; 113:2151-6. Endosnasal surgery for Contact Point Headaches: a 10-year longitudinal study Welge-Leussen A, et al. Laryngoscope 2003; 113:2151-6. • 20 patients treated for headaches by surgery for contact points over 18 year period • average follow-up of 112 months • 6 pain free, 7 significantly improved (65%) • 7 no better (2 recurred 7 and 8 years later)
• Does contact point act as migraine trigger? • 66 patients with medically refractory headaches and negative CT scans for inflammatory disease diagnosed with rhinogenic headache • Underwent ESS +/-septoplasty for: • 21 patients with refractory migraine or transformed migraine, evidence of contact points on CT scan, and positive response to lidocaine application to contact area underwent ESS and septoplasty • HA severity reduced from 7.6 to 3.8 (p=.0001) • HA related disability reduced from 5.6 to 1.8 (p=.0001) • 76.2% had >50% pain reduction, 95.8% had >25% reduction
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